超早产儿呼吸支持研究进展
Research Progress on Respiratory Support for Extremely Preterm Infants
DOI: 10.12677/ACM.2023.135987, PDF,   
作者: 刘万娇:重庆医科大学附属儿童医院新生儿科,重庆;李 芳*:重庆市妇幼保健院,重庆医科大学附属妇女儿童医院,重庆
关键词: 超早产儿呼吸管理综述Extremely Preterm Infants Respiratory Management Review
摘要: 早产是全球婴儿死亡和发病的主要原因,其中超早产儿常合并母孕期高危因素,出生时各器官发育不成熟,即使存活的超早产儿在住院期间也可能会存在一些严重并发症影响其生存质量,是新生儿重症监护病房的救治重点。本文就超早产儿呼吸管理策略进行综述,为优化超早产儿早期干预提供依据。
Abstract: Preterm birth is the leading cause of infant mortality and morbidity worldwide, among which ex-tremely preterm infants (EPI) are often combined with maternal high-risk factors during pregnancy, and the organs are immature at birth; even surviving extremely preterm infants may have some severe complications during hospitalization that affect their quality of life, which is the focus of treatment in neonatal intensive care units (NICU). This article reviews the respiratory management strategies of extremely preterm infants to provide a basis for optimizing early intervention in ex-tremely preterm infants.
文章引用:刘万娇, 李芳. 超早产儿呼吸支持研究进展[J]. 临床医学进展, 2023, 13(5): 7056-7068. https://doi.org/10.12677/ACM.2023.135987

参考文献

[1] NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes (1995) Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA, 273, 413-418. [Google Scholar] [CrossRef
[2] Committee on Obstetric Practice (2017) Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstetrics & Gynecology, 130, e102-e109. [Google Scholar] [CrossRef
[3] Sweet, D.G., Carnielli, V.P., Greisen, G., Hallman, M., Klebermass-Schrehof, K., et al. (2023) European Consensus Guidelines on the Management of Respiratory Distress Syndrome: 2022 Update. Neonatology, 120, 3-23. [Google Scholar] [CrossRef] [PubMed]
[4] Travers, C.P., Carlo, W.A., McDonald, S.A., et al. (2018) Mortality and Pulmonary Outcomes of Extremely Preterm Infants Exposed to Antenatal Corticosteroids. American Journal of Obstet-rics & Gynecology, 218, 130.e1-130.e13.
[5] Blankenship, S.A., Brown, K.E., Simon, L.E., Stout, M.J. and Tuuli, M.G. (2020) Antenatal Corticosteroids in Preterm Small-for-Gestational Age Infants: A Systematic Review and Me-ta-Analysis. American Journal of Obstetrics & Gynecology MFM, 2, Article ID: 100215. [Google Scholar] [CrossRef] [PubMed]
[6] McGoldrick, E., Stewart, F., Parker, R. and Dalziel, S.R. (2020) Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. Cochrane Data-base of Systematic Reviews, No. 12, CD004454. [Google Scholar] [CrossRef
[7] Roberts, D., Brown, J., Medley, N. and Dalziel, S.R. (2017) Antenatal Corticosteroids for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. Cochrane Database of Systematic Reviews, 3, CD004454. [Google Scholar] [CrossRef
[8] Deshmukh, M. and Patole, S. (2018) Antenatal Cortico-steroids in Impending Preterm Deliveries before 25 Weeks’ Gestation. ADC Fetal & Neonatal Edition, 103, F173-F176. [Google Scholar] [CrossRef] [PubMed]
[9] Hallman, M., Ronkainen, E., Saarela, T.V. and Marttila, R.H. (2022) Management Practices during Perinatal Respiratory Transition of Very Premature Infants. Frontiers in Pedi-atrics, 10, Article ID: 862038. [Google Scholar] [CrossRef] [PubMed]
[10] Seckl, J.R. (2004) Prenatal Glucocorticoids and Long-Term Pro-gramming. European Journal of Endocrinology, Supplement, 151, U49-U62. [Google Scholar] [CrossRef] [PubMed]
[11] Ninan, K., Liyanage, S.K., Murphy, K.E., Asztalos, E.V. and McDonald, S.D. (2022) Evaluation of Long-Term Outcomes Associated with Preterm Exposure to Antenatal Corticosteroids: A Systematic Review and Meta-Analysis. JAMA Pediatrics, 176, e220483. [Google Scholar] [CrossRef] [PubMed]
[12] American College of Obstetricians and Gynecologists Com-mittee on Obstetric Practice (2017) Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstetrics & Gynecology, 130, e102-e109. [Google Scholar] [CrossRef
[13] Wapner, R.J., Sorokin, Y., Mele, L., Johnson, F., Dudley, D.J., Spong, C.Y., et al. (2007) Long-Term Outcomes after Repeat Doses of Antenatal Corticosteroids. The New Eng-land Journal of Medicine, 357, 1190-1198. [Google Scholar] [CrossRef
[14] Crowther, C.A., McKinlay, C.J., Middleton, P. and Harding, J.E. (2015) Repeat Doses of Prenatal Corticosteroids for Women at Risk of Preterm Birth for Improving Neonatal Health Outcomes. Cochrane Database of Systematic Reviews, 7, CD003935. [Google Scholar] [CrossRef
[15] Brownfoot, F.C., Gagliardi, D.I., Bain, E., Middleton, P. and Crowther, C.A. (2013) Different Corticosteroids and Regimens for Accelerating Fetal Lung Maturation for Women at Risk of Preterm Birth. Cochrane Database of Systematic Reviews, No. 8, CD006764. [Google Scholar] [CrossRef
[16] Subramaniam, P., Ho, J.J. and Davis, P.G. (2021) Prophylactic or Very Early Initiation of Continuous Positive Airway Pressure (CPAP) for Preterm Infants. Cochrane Database of Systematic Reviews, 10, CD001243. [Google Scholar] [CrossRef
[17] Kirpalani, H., Ratcliffe, S.J., Keszler, M., Davis, P.G., et al. (2019) Effect of Sustained Inflations vs Intermittent Positive Pressure Ventilation on Bronchopulmonary Dysplasia or Death among Extremely Preterm Infants: The SAIL Randomized Clinical Trial. JAMA, 321, 1165-1175. [Google Scholar] [CrossRef] [PubMed]
[18] Jobe, A.H. (1993) Pulmonary Surfactant Therapy. The New England Journal of Medicine, 328, 861-868. [Google Scholar] [CrossRef
[19] Soll, R.F. (2000) Synthetic Surfactant for Respiratory Dis-tress Syndrome in Preterm Infants. Cochrane Database of Systematic Reviews, 1998, CD001149. [Google Scholar] [CrossRef
[20] Jena, S.R., Bains, H.S., Pandita, A., Verma, A., Gupta, V., Kal-lem, V.R., et al. (2019) Surfactant Therapy in Premature Babies: SurE or InSurE. Pediatric Pulmonology, 54, 1747-1752. [Google Scholar] [CrossRef] [PubMed]
[21] Pandita, A. and Panza, R. (2020) Sure or Insure. Pediatric Pulmonology, 55, 18-19. [Google Scholar] [CrossRef] [PubMed]
[22] Kribs, A., Roll, C., Göpel, W., Wieg, C., Groneck, P., Laux, R., et al. (2015) Nonintubated Surfactant Application vs Conventional Therapy in Extremely Preterm Infants: A Randomized Clinical Trial. JAMA Pediatrics, 169, 723-730. [Google Scholar] [CrossRef] [PubMed]
[23] Abdel-Latif, M.E., Davis, P.G., Wheeler, K.I., de Paoli, A.G. and Dargaville, P.A. (2021) Surfactant Therapy via Thin Catheter in Preterm Infants with or at Risk of Respiratory Dis-tress Syndrome. Cochrane Database of Systematic Reviews, 5, CD011672. [Google Scholar] [CrossRef
[24] Sweet, D.G., Carnielli, V., Greisen, G., Hallman, M., Ozek, E., Te Pas, A., et al. (2019) European Consensus Guidelines on the Management of Respiratory Distress Syn-drome—2019 Update. Neonatology, 115, 432-450. [Google Scholar] [CrossRef] [PubMed]
[25] Köroğlu, O.A., MacFarlane, P.M., Balan, K.V., et al. (2014) An-ti-Inflammatory Effect of Caffeine Is Associated with Improved Lung Function after Lipopolysaccharide-Induced Amni-onitis. Neonatology, 106, 235-240. [Google Scholar] [CrossRef] [PubMed]
[26] Chavez, L. and Bancalari, E. (2022) Caffeine: Some of the Evidence behind Its Use and Abuse in the Preterm Infant. Neonatology, 119, 428-432. [Google Scholar] [CrossRef] [PubMed]
[27] Schmidt, B., Roberts, R.S., Davis, P., Doyle, L.W., Barrington, K.J., Ohlsson, A., et al. (2006) Caffeine Therapy for Apnea of Prematurity. The New England Journal of Medicine, 354, 2112-2121. [Google Scholar] [CrossRef
[28] Schmidt, B., Roberts, R.S., Davis, P., Doyle, L.W., Barrington, K.J., Ohlsson, A., et al. (2007) Long-Term Effects of Caffeine Therapy for Apnea of Prematurity. The New England Journal of Medicine, 357, 1893-1902. [Google Scholar] [CrossRef
[29] Schmidt, B. anderson, P.J., Doyle, L.W., Dewey, D., Grunau, R.E., Asztalos, E.V., et al. (2012) Survival without Disability to Age 5 Years after Neonatal Caffeine Therapy for Apnea of Prematurity. JAMA, 307, 275-282. [Google Scholar] [CrossRef] [PubMed]
[30] National Guideline Alliance (UK) (2019) Specialist Neonatal Respira-tory Care for Babies Born Preterm. National Institute for Health and Care Excellence (UK), London.
https://www.nice.org.uk/guidance/ng124
[31] Abu-Shaweesh, J.M. and Martin, R.J. (2017) Caffeine Use in the Neonatal Intensive Care Unit. Seminars in Fetal and Neonatal Medicine, 22, 342-347. [Google Scholar] [CrossRef] [PubMed]
[32] Patel, R.M., Leong, T., Carlton, D.P. and Vyas-Read, S. (2013) Early Caffeine Therapy and Clinical Outcomes in Extremely Preterm Infants. Journal of Perinatology, 33, 134-140. [Google Scholar] [CrossRef] [PubMed]
[33] Katheria, A.C., Sauberan, J.B., Akotia, D., et al. (2015) A Pilot Random-ized Controlled Trial of Early versus Routine Caffeine in Extremely Premature Infants. American Journal of Perinatology, 32, 879-886. [Google Scholar] [CrossRef] [PubMed]
[34] Dekker, J., Hooper, S.B., van Vonderen, J.J., et al. (2017) Caffeine to Improve Breathing Effort of Preterm Infants at Birth: A Randomized Controlled Trial. Pediatric Research, 82, 290-296. [Google Scholar] [CrossRef] [PubMed]
[35] Dix, L.M.L., van Bel, F., Baerts, W. and Lemmers, P.M.A. (2018) Effects of Caffeine on the Preterm Brain: An Observational Study. Early Human Development, 120, 17-20. [Google Scholar] [CrossRef] [PubMed]
[36] Silva, C.G., Métin, C., Fazeli, W., et al. (2013) Adenosine Receptor Antagonists Including Caffeine Alter Fetal Brain Development in Mice. Science Translational Medicine, 5, 197ra104. [Google Scholar] [CrossRef] [PubMed]
[37] Hvolgaard, M.S., Obel, C., Olsen, J., Niclasen, J.,et al. (2017) Maternal Caffeine Consumption during Pregnancy and Behavioral Disorders in 11-Year-Old Offspring: A Danish National Birth Cohort Study. The Journal of Pediatrics, 189, 120-127.e1. [Google Scholar] [CrossRef] [PubMed]
[38] Vesoulis, Z.A., McPherson, C., Neil, J.J., Mathur, A.M. and In-der, T.E. (2016) Early High-Dose Caffeine Increases Seizure Burden in Extremely Preterm Neonates: A Preliminary Study. Journal of Caffeine Research, 6, 101-107. [Google Scholar] [CrossRef] [PubMed]
[39] Liu, S.S., Zhang, X.L., Liu, Y.C., Yuan, X., et al. (2020) Early Applica-tion of Caffeine Improves White Matter Development in Very Preterm Infants. Respiratory Physiology & Neurobiology, 281, Article ID: 103495. [Google Scholar] [CrossRef] [PubMed]
[40] Patel, R.M., Zimmerman, K., Carlton, D.P., et al. (2017) Early Caffeine Prophylaxis and Risk of Failure of Initial Continuous Positive Airway Pressure in Very Low Birth Weight In-fants. The Journal of Pediatrics, 190, 108-111.e1. [Google Scholar] [CrossRef] [PubMed]
[41] Lim, S.Y., May, C.B., Johnson, P.N., et al. (2023) Caffeine Dos-ing in Premature Neonates: Impact of Birth Weight on a Pharmacokinetic Simulation Study. Pediatric Research, 93, 696-700. [Google Scholar] [CrossRef] [PubMed]
[42] Puia-Dumitrescu, M., Smith, P.B., Zhao, J., et al. (2019) Dosing and Safety of Off-Label Use of Caffeine Citrate in Premature Infants. The Journal of Pediatrics, 211, 27-32.e1. [Google Scholar] [CrossRef] [PubMed]
[43] Eichenwald, E.C. (2016) Committee on Fetus and Newborn, American Academy of Pediatrics. Apnea of Prematurity. Pediatrics, 137, e20153757. [Google Scholar] [CrossRef] [PubMed]
[44] Support Study Group of the Eunice Kennedy Shriver NICHD Neo-natal Research Network, et al. (2010) Early CPAP versus Surfactant in Extremely Preterm Infants. The New England Journal of Medicine, 362, 1970-1979. [Google Scholar] [CrossRef
[45] Fischer, H.S. and Bührer, C. (2013) Avoiding Endotracheal Ventila-tion to Prevent Bronchopulmonary Dysplasia: A Meta-Analysis. Pediatrics, 132, e1351-e1361. [Google Scholar] [CrossRef] [PubMed]
[46] Wright, C.J., Polin, R.A. and Kirpalani, H. (2016) Continuous Posi-tive Airway Pressure to Prevent Neonatal Lung Injury: How Did We Get Here, and How Do We Improve? The Journal of Pediatrics, 173, 17-24.e12. [Google Scholar] [CrossRef] [PubMed]
[47] Stoll, B.J., Hansen, N.I., Bell, E.F., et al. (2015) Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. JAMA, 314, 1039-1051. [Google Scholar] [CrossRef] [PubMed]
[48] Dargaville, P.A., Gerber, A., Johansson, S., et al. (2016) Incidence and Outcome of CPAP Failure in Preterm Infants. Pediatrics, 138, e20153985. [Google Scholar] [CrossRef] [PubMed]
[49] Fernandez-Gonzalez, S.M., Sucasas Alonso, A., Ogando Martinez, A. and Avila-Alvarez, A. (2022) Incidence, Predictors and Outcomes of Noninvasive Ventilation Failure in Very Preterm Infants. Children (Basel), 9, 426. [Google Scholar] [CrossRef] [PubMed]
[50] Lemyre, B., Davis, P.G., De Paoli, A.G. and Kirpalani, H. (2017) Nasal Intermittent Positive Pressure Ventilation (NIPPV) versus Nasal Continuous Positive Airway Pressure (NCPAP) for Preterm Neonates after Extubation. Cochrane Database of Systematic Reviews, 2, CD003212. [Google Scholar] [CrossRef
[51] Ferguson, K.N., Roberts, C.T., Manley, B.J. and Davis, P.G. (2017) Interventions to Improve Rates of Successful Extubation in Preterm Infants. A Systematic Review and Me-ta-Analysis. JAMA Pediatrics, 171, 165-174. [Google Scholar] [CrossRef] [PubMed]
[52] Schulzke, S.M. and Stoecklin, B. (2022) Update on Ventila-tory Management of Extremely Preterm Infants—A Neonatal Intensive Care Unit Perspective. Pediatric Anesthesia, 32, 363-371. [Google Scholar] [CrossRef] [PubMed]
[53] Kostekci, Y.E., Okulu, E., Bakirarar, B., et al. (2022) Nasal Con-tinuous Positive Airway Pressure vs. Nasal Intermittent Positive Pressure Ventilation as Initial Treatment after Birth in Extremely Preterm Infants. Frontiers in Pediatrics, 10, Article ID: 870125. [Google Scholar] [CrossRef] [PubMed]
[54] Li, J., Li, X., Huang, X. and Zhang, Z. (2019) Noninvasive High-Frequency Oscillatory Ventilation as Respiratory Support in Preterm Infants: A Meta-Analysis of Randomized Controlled Trials. Respiratory Research, 20, 58. [Google Scholar] [CrossRef] [PubMed]
[55] Cheong, J.L.Y. and Doyle, L.W. (2018) An Update on Pulmonary and Neurodevelopmental Outcomes of Bronchopulmonary Dysplasia. Seminars in Perinatology, 42, 478-484. [Google Scholar] [CrossRef] [PubMed]
[56] Wai, K.C., Keller, R.L., Lusk, L.A., et al. (2017) Characteristics of Extremely Low Gestational Age Newborns Undergoing Tracheotomy: A Secondary Analysis of the Trial of Late Sur-factant Randomized Clinical Trial. JAMA Otolaryngology—Head & Neck Surgery, 143, 13-19. [Google Scholar] [CrossRef] [PubMed]
[57] Klingenberg, C., Wheeler, K.I., McCallion, N., et al. (2017) Vol-ume-Targeted versus Pressure-Limited Ventilation in Neonates. Cochrane Database of Systematic Reviews, 10, CD003666. [Google Scholar] [CrossRef
[58] De Jaegere, A.P., Deurloo, E.E., van Rijn, R.R., et al. (2016) Individualized Lung Recruitment during High-Frequency Ventilation in Preterm Infants Is Not Associated with Lung Hyperinflation and Air Leaks. European Journal of Pediatrics, 175, 1085-1090. [Google Scholar] [CrossRef] [PubMed]
[59] Lin, H.Z., Lin, W.H., Lin, S.H., et al. (2022) Application of High-Frequency Oscillation Ventilation Combined with Volume Guarantee in Preterm Infants with Acute Hypoxic Res-piratory Failure after Patent Ductus Arteriosus Ligation. The Heart Surgery Forum, 25, E709-E714. [Google Scholar] [CrossRef] [PubMed]
[60] Rodríguez Sánchez de la Blanca, A., Sánchez, L.M., González, P.N., Ramos, N.C., et al. (2020) New Indicators for Optimal Lung Recruitment during High Frequency Oscillator Ventilation. Pediat-ric Pulmonology, 55, 3525-3531. [Google Scholar] [CrossRef] [PubMed]